-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
January 8: The Week in Cancer News
Two extremely rare cases of cancer being passed from mother to child observed in Japan, and advice on COVID-19 vaccines for cancer patients.
by Bradley Jones
-
Colorectal Cancer Screenings at Home
Stool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
From the Editor-in-Chief
Intercepting Cancer by Tackling PrecancerResearch on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
-
Are Liquid Biopsies Ready for the Clinic?
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
-
Forward Look
Scanning DisparitiesWhether lung cancer patients receive PET scans depends on race, according to a study.
by Ashley P. Taylor
-
Healthy Habits
Health NutsEating tree nuts may decrease cancer risk, especially for cancers of the digestive system.
by Tara Santora
-
Forward Look
Doing More With LessHypofractionation may allow patients to finish radiation treatment sooner.
by Stephen Ornes
-
Forward Look
What’s Next? Winter 2020/2021Using deep learning to detect tumor mutations.
by Christina Bennett
-
Multiple Myeloma: Choosing Your Path
New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
Cancer Talk
Targeted Therapy Approval Adds Option for Advanced Breast Cancer Without Mutation
A new treatment for people with hormone receptor-positive, HER2-negative disease blocks multiple proteins in a key pathway for treatment resistance.
by Ashley P. Taylor
Amanda Peet Discusses Her Lobular Breast Cancer DiagnosisThe ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
